Abstract
Objective: In order to inform integrated, person-centered interventions, this studyaimed to determine the prevalence of having both a raised blood glucose (BG) andblood pressure (BP) in India, and its variation among states and population groups.
Methods: We pooled data from three large household surveys (the AHS, DLHS-4, andNFHS-4), which were carried out between 2012 and 2016 and included adults aged≥15 years. Raised BG was defined as having a plasma glucose reading ≥126 mg/dl iffasted and ≥200 mg/dl if not fasted, and raised BP as a systolic BP ≥140 mmHg ordiastolic BP ≥90 mmHg. The prevalence of having a concurrently raised BG and BP(‘co-morbid’) was age-standardized to India’s national population structure, anddisaggregated by sex, age group, BMI group, rural-urban residency, household wealthquintile, education, state, and region.
Results: The age-standardized prevalence of the co-morbidity was 1.5% (95% CI, 1.5-1.5), varying by a factor of 8.3 between states. Among those aged ≥50 years, 4.5%(95% CI, 4.3-4.7) with a BMI<23.0kg/m2 and 16.1% (95% CI, 15.0-17.4) with a BMI≥30kg/m2 were co-morbid. Age, BMI, household wealth quintile, male sex, and urbanlocation were all positively associated with the co-morbidity.
Conclusions: A substantial proportion of India’s population had both a raised BG andBP, calling for integrated interventions to reduce CVD risk. We identified large variationamong states, age groups, and by rural-urban residency, which can inform healthsystem planning and the targeting of interventions, such as appropriate screeningprograms, to those most in need.
Methods: We pooled data from three large household surveys (the AHS, DLHS-4, andNFHS-4), which were carried out between 2012 and 2016 and included adults aged≥15 years. Raised BG was defined as having a plasma glucose reading ≥126 mg/dl iffasted and ≥200 mg/dl if not fasted, and raised BP as a systolic BP ≥140 mmHg ordiastolic BP ≥90 mmHg. The prevalence of having a concurrently raised BG and BP(‘co-morbid’) was age-standardized to India’s national population structure, anddisaggregated by sex, age group, BMI group, rural-urban residency, household wealthquintile, education, state, and region.
Results: The age-standardized prevalence of the co-morbidity was 1.5% (95% CI, 1.5-1.5), varying by a factor of 8.3 between states. Among those aged ≥50 years, 4.5%(95% CI, 4.3-4.7) with a BMI<23.0kg/m2 and 16.1% (95% CI, 15.0-17.4) with a BMI≥30kg/m2 were co-morbid. Age, BMI, household wealth quintile, male sex, and urbanlocation were all positively associated with the co-morbidity.
Conclusions: A substantial proportion of India’s population had both a raised BG andBP, calling for integrated interventions to reduce CVD risk. We identified large variationamong states, age groups, and by rural-urban residency, which can inform healthsystem planning and the targeting of interventions, such as appropriate screeningprograms, to those most in need.
| Original language | English |
|---|---|
| Pages (from-to) | 1822–1831 |
| Number of pages | 10 |
| Journal | Journal of Hypertension |
| Volume | 37 |
| Issue number | 9 |
| DOIs | |
| Publication status | Published - 1 Sept 2019 |
Keywords
- Diabetes
- Hypertension
- India
- blood Glucose
- blood pressure
- cardiovascular disease
- co-morbidity
Access to Document
- Anne_C._Bischops_et_al_The_prevalence_of_concurrently_raised_blood_glucose_Journal_of_Hypertension_2019
Checked for eligibility: 27/03/2019 This document is the Author Accepted Manuscript version of a published work, Egan, B.M., 2019. The prevalence of concurrently raised blood glucose and blood pressure in India. Journal of hypertension, 37(9), pp.1788-1789, which appears in its final form at: https://doi.org/10.1097/HJH.0000000000002114.